It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2014.
2014 | Hyderabad, Telangana, India | ActiveClaribel Pharmaceuticals Private Limited, a active private limited company, was established on 05 November 2014 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U33111TG2014PTC096243. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Apsingiker Sravan Kumar (Director), Shaik Mustafa (Director), Katta Bharath Kumar (Director). Past directors included Madishetty Venkata Ramana. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 2-1-290/2 Nagole, Hyderabad, Telangana, 500068.
U33111TG2014PTC096243
096243
05 November 2014
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Claribel Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Apsingiker Sravan Kumar | Director | 05 Nov 2014 | Current |
| Shaik Mustafa | Director | 05 Nov 2014 | Current |
| Katta Bharath Kumar | Director | 05 Nov 2014 | Current |
| Gandwaid Ravinder Rao | Director | 05 Nov 2014 | Current |
| Ashok Manda | Director | 05 Nov 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Apr 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Claribel Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.26% increase. The company also saw a substantial improvement in profitability, with a 40.35% increase in profit. The company's net worth Soared by an impressive increase of 15.81%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Claribel Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Claribel Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Claribel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Claribel Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Claribel Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Claribel Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.
Progress on Apsingiker Sravan Kumar was appointed as a Director was appointed as a Director on 05 Nov 2014 & has been associated with this company since 11 years 29 days . was documented.
The activity Shaik Mustafa was appointed as a Director was appointed as a Director on 05 Nov 2014 & has been associated with this company since 11 years 29 days . was completed.
Katta Bharath Kumar was appointed as a Director was appointed as a Director on 05 Nov 2014 & has been associated with this company since 11 years 29 days . was recorded as a recent event.
Progress on Gandwaid Ravinder Rao was appointed as a Director was appointed as a Director on 05 Nov 2014 & has been associated with this company since 11 years 29 days . was documented.
The CIN of Claribel Pharmaceuticals Private Limited is U33111TG2014PTC096243.
Claribel Pharmaceuticals Private Limited is headquartered at 2-1-290/2 Nagole, Hyderabad, Telangana, 500068.
Claribel Pharmaceuticals Private Limited was incorporated on 05 November 2014.
The current directors of Claribel Pharmaceuticals Private Limited are
The primary industry of Claribel Pharmaceuticals Private Limited is Trade.
Claribel Pharmaceuticals Private Limited is unlisted.
The authorized capital of Claribel Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Claribel Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX